AR and neoplasm: With the aim to further investigate the role of the androgen/AR pathway in breast cancer development, we evaluated the relationships of AR expression with testosterone levels, with age and body mass index (BMI) of patients and with selected tumor characteristics, both in the whole cohort and in age categories (<65 and ≥65 years).